UnitedHealth Group Incorporated $UNH Shares Purchased by St. Johns Investment Management Company LLC

St. Johns Investment Management Company LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 38.1% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 3,592 shares of the healthcare conglomerate’s stock after purchasing an additional 991 shares during the period. St. Johns Investment Management Company LLC’s holdings in UnitedHealth Group were worth $1,121,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP boosted its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. Bank of New York Mellon Corp boosted its position in UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock valued at $4,257,131,000 after buying an additional 196,696 shares during the last quarter. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after purchasing an additional 847,054 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $365.47 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $331.00 billion, a price-to-earnings ratio of 15.83, a price-to-earnings-growth ratio of 2.36 and a beta of 0.47. The company has a 50-day moving average price of $333.70 and a two-hundred day moving average price of $341.28.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the company posted $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on UNH. Truist Financial upped their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Piper Sandler cut their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Bank of America upped their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Mizuho increased their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Finally, Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus price target of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.